Delivery Order SPE2DB22D3401-SPE2DB25FT6EZ
Award Date 9/15/25
Potential Completion Date 10/6/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,434.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rhophylac 300 mcg/2 mL syringes, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. The contract carries a ceiling value of $1,434.00 and is scheduled for completion by September 29, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- The Defense Logistics Agency awarded a $1,434.00 delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 MCG/2 ML syringes on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,147.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under a larger contract vehicle. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,824.00 delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Rhophylac 300 micrograms per 2 milliliter syringes. This is a competitively awarded, non-set-aside contract utilizing firm fixed pricing, with an ultimate completion date of October 2, 2025. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency awarded a $1,434.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 MCG/2 ML syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a pediatric immunoglobulin product sourced through AmerisourceBergen's extensive federal pharmaceutical supply network. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $4,590.10 for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- The Defense Logistics Agency awarded a $2,868.00 delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 mcg/2 ml syringes on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rhophylac is an immunoglobulin product used for passive immunization purposes, typically administered in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.00 firm fixed-price contract is for the supply of 4567321981 ! RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,434.00 to AmerisourceBergen Drug Corp for Rhophylac 150mcg/ml (2 units), a blood plasma product used in hemolytic disease prevention. Awarded on September 4, 2025, with completion expected by September 5, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement executed through the company's broader indefinite delivery contract vehicle. The award carries no...